Currently, Meng Jiao Jiang holds the position of Chairman of CMAB BioPharma (Suzhou) Inc. Ms. Jiang is also on the board of Clarus Therapeutics, Inc., I-Mab Bio-tech (Tianjin) Co., Ltd. and Nuance Pharma (Shanghai) Co., Ltd.
In the past she occupied the position of Managing Director at ARC Investment Partners LLC, Associate Director at BDA Partners, Inc. and Analyst at UBS Investment Bank (US).
Ms. Jiang received an undergraduate degree from Wellesley College.
|